The emergence of world class "best of breed" third-party software solutions, or apps, has driven the need for EHR integration ...

The family-owned MedTech company KARL STORZ is pleased to announce the acquisition of the medical business of T1V, a US-based ...

CI Checked, the evolution of Commercial Investigations, a leading provider of background screening solutions, is pleased to ...

A national magazine recognizes Omaha -based company for its innovative model in providing "strong jobs in unconventional ...

The Lenovo Yoga Slim 9i is the world's first* CUD (camera-under-display) laptop, enhanced with Visionary.ai's image ...

Moloco, a leader in operational machine learning (ML) and performance advertising, announced that Iris Chen has joined as ...

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205321953/en/ ...

(GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company, today announced the launch of Discover23®, a new research offering enabling authorized collaborators to securely ...

Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases. Angitia is currently ...

To access the live webcast of BridgeBio’s presentation, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at A replay of the webcast will be ...

Cheshire Cat, Queen of Hearts and Knave of Hearts: Available through Shards throughout the campaign.

Foresight was previously notified by Nasdaq on September 3, 2024, that it was not in compliance with the minimum bid price rule because its American Depositary Shares (“ADSs”) failed to meet the ...